Development of non-natural flavanones as antimicrobial agents

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Fowler, Zachary L ^a   Shah, Karan ^b   Panepinto, John C ^c   Jacobs, Amy ^c   Koffas, Mattheos A G ^d  

^a PRAXAIR INC   (United States)

^b the State University of New York   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d RENSSELAER POLYTECHNIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 FLUOROFLAVANONE; 3 FLUOROFLAVANONE; 3 HYDROXYFLAVANONE; 4 CHLOROFLAVANONE; 4 FLUORO 3 BROMOFLAVANONE; 4 FLUORO 3 CHLOROFLAVANONE; 4 FLUORO 3 METHOXYFLAVANONE; 4 FLUOROFLAVANONE; ANTIBIOTIC AGENT; ANTIBIOTIC G 418; ERIODICTOYL; FLAVANONE DERIVATIVE; NARINGENIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; BACILLUS SUBTILIS; BACTERIAL GROWTH; CELL VIABILITY; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DRUG EFFICACY; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; ESCHERICHIA COLI; FUNGUS GROWTH; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SACCHAROMYCES CEREVISIAE; CHEMISTRY; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; HELA CELL; HUMAN; MICROBIOLOGICAL EXAMINATION;

ASPERGILLUS FUMIGATUS; BACILLUS SUBTILIS; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; FILOBASIDIELLA NEOFORMANS; FUNGI;

ANTI-INFECTIVE AGENTS; ASPERGILLUS FUMIGATUS; BACILLUS SUBTILIS; CRYPTOCOCCUS NEOFORMANS; ESCHERICHIA COLI; FLAVANONES; HELA CELLS; HUMANS; MICROBIAL SENSITIVITY TESTS; SACCHAROMYCES CEREVISIAE;

EID: 80054790835     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025681     Document Type: Article

References (34)

1. Juliano RL, Ling V, (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455: 152-162.
2. Ball PR, Chopra I, Eccles SJ, (1977) Accumulation of tetracyclines by Escherichia coli K-12. Biochem Biophys Res Commun 77: 1500-1507.
3. Schumacher A, Steinke P, Bohnert JA, Akova M, Jonas D, et al. (2006) Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Enterobacteriaceae other than Escherichia coli. Journal of Antimicrobial Chemotherapy 57: 344-348.
4. Hannula M, Hanninen ML, (2008) Effect of putative efflux pump inhibitors and inducers on the antimicrobial susceptibility of Campylobacter jejuni and Campylobacter coli. J Med Microbiol 57: 851-855.
5. Tegos G, Stermitz FR, Lomovskaya O, Lewis K, (2002) Multidrug pump inhibitors uncover remarkable activity of plant antimicrobials. Antimicrob Agents Chemother 46: 3133-3141.
6. Kaefer CM, Milner JA, (2008) The role of herbs and spices in cancer prevention. J Nutr Biochem 19: 347-361.
7. Forkmann G, Martens S, (2001) Metabolic engineering and applications of flavonoids. Current Opinion in Biotechnology 12: 155-160.
8. Harborne JB, Williams CA, (2000) Advances in flavonoid research since 1992. Phytochemistry 55: 481-504.
9. Chemler JA, Fowler ZL, Koffas MA, Leonard E, (2009) Trends in microbial synthesis of natural products and biofuels. Advances in Enzymology and Related Areas of Molecular Biology 76: 151-217.
10. Bavaresco L, Vezzulli S, Civardi S, Gatti M, Battilani P, et al. (2008) Effect of lime-induced leaf chlorosis on ochratoxin A, trans-resveratrol, and epsilon-viniferin production in grapevine (Vitis vinifera L.) berries infected by Aspergillus carbonarius. J Agric Food Chem 56: 2085-2089.
11. Sobolev VS, Neff SA, Gloer JB, (2009) New stilbenoids from peanut (Arachis hypogaea) seeds challenged by an Aspergillus caelatus strain. J Agric Food Chem 57: 62-68.
12. Chen ZH, Zheng CJ, Sun LP, Piao HR, (2010) Synthesis of new chalcone derivatives containing a rhodanine-3-acetic acid moiety with potential anti-bacterial activity. European Journal of Medicinal Chemistry 45: 5739-5743.
13. Sivakumar PM, Ganesan S, Veluchamy P, Doble M, (2010) Novel chalcones and 1,3,5-triphenyl-2-pyrazoline derivatives as antibacterial agents. Chem Biol Drug Des 76: 407-411.
14. Abdel Ghani SB, Weaver L, Zidan ZH, Ali HM, Keevil CW, et al. (2008) Microwave-assisted synthesis and antimicrobial activities of flavonoid derivatives. Bioorg Med Chem Lett 18: 518-522.
15. Nowakowska Z, (2007) A review of anti-infective and anti-inflammatory chalcones. European Journal of Medicinal Chemistry 42: 125-137.
16. Arif T, Bhosale JD, Kumar N, Mandal TK, Bendre RS, et al. (2009) Natural products-antifungal agents derived from plants. J Asian Nat Prod Res 11: 621-638.
17. Rusin A, Krawczyk Z, Grynkiewicz G, Gogler A, Zawisza-Puchalka J, et al. (2010) Synthetic derivatives of genistein, their properties and possible applications. Acta Biochim Pol 57: 23-34.
18. Saleem M, Nazir M, Ali MS, Hussain H, Lee YS, et al. (2010) Antimicrobial natural products: an update on future antibiotic drug candidates. Nat Prod Rep 27: 238-254.
19. Srinivas NR, (2010) Baicalin, an emerging multi-therapeutic agent: pharmacodynamics, pharmacokinetics, and considerations from drug development perspectives. Xenobiotica 40: 357-367.
20. Chemler JA, Yan Y, Leonard E, Koffas MA, (2007) Combinatorial mutasynthesis of flavonoid analogues from acrylic acids in microorganisms. Org Lett 9: 1855-1858.
21. Zhou H, Xie X, Tang Y, (2008) Engineering natural products using combinatorial biosynthesis and biocatalysis. Curr Opin Biotechnol 19: 590-596.
22. Fowler ZL, Koffas MA, (2009) Biosynthesis and biotechnological production of flavanones: current state and perspectives. Applied Microbiology and Biotechnology 83: 799-808.
23. Cowan MM, (1999) Plant products as antimicrobial agents. Clin Microbiol Rev 12: 564-582.
24. Fowler ZL, Baron CM, Panepinto JC, Koffas MA, (2011) Melanization of flavonoids by fungal and bacterial laccases. Yeast 28: 181-188.
25. Lombardino JG, Lowe JA 3rd, (2004) The role of the medicinal chemist in drug discovery-then and now. Nat Rev Drug Discov 3: 853-862.
26. Moorthy NS, Singh RJ, Singh HP, Gupta SD, (2006) Synthesis, biological evaluation and in silico metabolic and toxicity prediction of some flavanone derivatives. Chem Pharm Bull (Tokyo) 54: 1384-1390.
27. Suzuki K, (2010) Lessons from total synthesis of hybrid natural products. Chem Rec 10: 291-307.
28. Fowler ZL, Gikandi WW, Koffas MA, (2009) Increased malonyl coenzyme A biosynthesis by tuning the Escherichia coli metabolic network and its application to flavanone production. Applied and Environmental Microbiology 75: 5831-5839.
29. Jakobsen A, Nielsen JN, Gyldenkerne N, Lindeberg J, (2005) Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphism in normal tissue as predictors of fluorouracil sensitivity. Journal of Clinical Oncology 23: 1365-1369.
30. Vooturi SK, Firestine SM, (2010) Synthetic membrane-targeted antibiotics. Curr Med Chem 17: 2292-2300.
31. Zhu XD, Williamson PR, (2004) Role of laccase in the biology and virulence of Cryptococcus neoformans. Fems Yeast Research 5: 1-10.
32. Selik RM, Chu SY, Ward JW, (1995) Trends in infectious diseases and cancers among persons dying of HIV infection in the United States from 1987 to 1992. Ann Intern Med 123: 933-936.
33. Yaipakdee P, Robertson LW, (2001) Enzymatic halogenation of flavanones and flavones. Phytochemistry 57: 341-347.
34. Cazarolli LH, Zanatta L, Alberton EH, Figueiredo MS, Folador P, et al. (2008) Flavonoids: prospective drug candidates. Mini Rev Med Chem 8: 1429-1440.